A Tale of Two Recoveries: US Hemostats & Sealants Q121 Market Recap

Written by Doug Devens | 6/3/21 1:30 PM

The US market for Hemostats and Sealants resumed its growth in Q121 as procedures climbed back towards normal.

While surgical procedures have not fully regained their pre-COVID levels, the US Hemostats and Sealants market grew in Q121 according to SmartTRAK Financial Dashboard. However, it continued to be a tale of two recoveries. CryoLife* and especially JNJ/Ethicon* posted solid gains for the quarter. However, as elective procedures continue to be behind pre-COVID levels, other manufacturers lagged by comparison.

Among the many topics covered in detail in our comprehensive Q121 Hemostats and Sealants Market Recap* are:

Complete Hemostats & Sealants Market Overview
SmartTRAK's Expert Analysis and Insights
US Hemostats and Sealants Market Resumes Growth
Hemostats Have Balanced Recovery
Sealants Lag Behind
Important Q121 Market Events

JNJ/Ethicon pulled ahead in the US Hemostats and Sealants market in Q121 as it continued to use its presence to lead the way back into hospitals, while second-place Baxter* saw its YoY decline. A large part of that difference was driven by ...

Read the entire Q121 Hemostats & Sealants Market Recap including news, data, charts, company revenues, shares and our expert analysis*

*The entire unedited article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

SmartTRAK is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis. Used by the top 15 Advanced Wound Care companies and 8 of the 10 top Orthopedic companies, we transform the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost. To learn more about SmartTRAK, click here.

View full post